ppjv2012
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00310271)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Influenza A virusImmunity, active
Influenza A virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ppjv2012
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00349037 | Phase 1 | Sep 1, 2006 | PowderMed |
| NCT00347529 | Phase 1 | Aug 1, 2006 | IQVIA, PowderMed |
| NCT00310271 | Phase 1 | Apr 1, 2006 | Pharmaceutical Research Associates, Inc. (PRA), PowderMed |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PowderMed | For profit | 3 | 3 | 1 | 2006 |
| IQVIA | For profit | 1 | 0 | 1 | 2006 |
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1